BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30379378)

  • 1. Pregnancy outcomes in women exposed to cancer chemotherapy.
    Danet C; Araujo M; Bos-Thompson MA; Portolan G; Gautier S; Vanlemmens L; Bonenfant S; Jonville-Béra AP; Cottin J; Vial T; Bavoux F; Montastruc JL; Damase-Michel C; Benevent J; Bourgeois-Mondon I; Lacroix I
    Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1302-1308. PubMed ID: 30379378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database.
    Clowse MEB; Scheuerle AE; Chambers C; Afzali A; Kimball AB; Cush JJ; Cooney M; Shaughnessy L; Vanderkelen M; Förger F
    Arthritis Rheumatol; 2018 Sep; 70(9):1399-1407. PubMed ID: 29623679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to aripiprazole during embryogenesis: a prospective multicenter cohort study.
    Bellet F; Beyens MN; Bernard N; Beghin D; Elefant E; Vial T
    Pharmacoepidemiol Drug Saf; 2015 Apr; 24(4):368-80. PubMed ID: 25683615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misoprostol exposure during the first trimester of pregnancy: Is the malformation risk varying depending on the indication?
    Auffret M; Bernard-Phalippon N; Dekemp J; Carlier P; Gervoise Boyer M; Vial T; Gautier S
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():188-192. PubMed ID: 27865944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry.
    Cardonick E; Usmani A; Ghaffar S
    Am J Clin Oncol; 2010 Jun; 33(3):221-8. PubMed ID: 19745695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying pregnancies in insurance claims data: Methods and application to retinoid teratogenic surveillance.
    MacDonald SC; Cohen JM; Panchaud A; McElrath TF; Huybrechts KF; Hernández-Díaz S
    Pharmacoepidemiol Drug Saf; 2019 Sep; 28(9):1211-1221. PubMed ID: 31328328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Terappel: description of a computerised database and examples of studies].
    Vial T; Gouraud A; Bernard N
    Therapie; 2014; 69(1):31-8. PubMed ID: 24698186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: An application to antiepileptic drug use in 4.9 million pregnant women in France.
    Blotière PO; Weill A; Dalichampt M; Billionnet C; Mezzarobba M; Raguideau F; Dray-Spira R; Zureik M; Coste J; Alla F
    Pharmacoepidemiol Drug Saf; 2018 Jul; 27(7):763-770. PubMed ID: 29763992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug in pregnancy: studies in the French database EFEMERIS].
    Damase-Michel C; Lacroix I; Hurault-Delarue C; Beau AB; Montastruc JL;
    Therapie; 2014; 69(1):91-100. PubMed ID: 24698193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of breast cancer during pregnancy: an observational study.
    Loibl S; Han SN; von Minckwitz G; Bontenbal M; Ring A; Giermek J; Fehm T; Van Calsteren K; Linn SC; Schlehe B; Gziri MM; Westenend PJ; Müller V; Heyns L; Rack B; Van Calster B; Harbeck N; Lenhard M; Halaska MJ; Kaufmann M; Nekljudova V; Amant F
    Lancet Oncol; 2012 Sep; 13(9):887-96. PubMed ID: 22902483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes.
    Djulus J; Koren G; Einarson TR; Wilton L; Shakir S; Diav-Citrin O; Kennedy D; Voyer Lavigne S; De Santis M; Einarson A
    J Clin Psychiatry; 2006 Aug; 67(8):1280-4. PubMed ID: 16965209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database.
    Lacroix I; Hurault C; Sarramon MF; Guitard C; Berrebi A; Grau M; Albouy-Cossard C; Bourrel R; Elefant E; Montastruc JL; Damase-Michel C
    Eur J Clin Pharmacol; 2009 Aug; 65(8):839-46. PubMed ID: 19365629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Chemotherapy Timing in Pregnancy With Congenital Malformation.
    van Gerwen M; Maggen C; Cardonick E; Verwaaijen EJ; van den Heuvel-Eibrink M; Shmakov RG; Boere I; Gziri MM; Ottevanger PB; Lok CAR; Halaska M; Shao LT; Struys I; van Dijk-Lokkart EM; Van Calsteren K; Fruscio R; Zola P; Scarfone G; Amant F;
    JAMA Netw Open; 2021 Jun; 4(6):e2113180. PubMed ID: 34106263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study.
    Coelho J; Beaugerie L; Colombel JF; Hébuterne X; Lerebours E; Lémann M; Baumer P; Cosnes J; Bourreille A; Gendre JP; Seksik P; Blain A; Metman EH; Nisard A; Cadiot G; Veyrac M; Coffin B; Dray X; Carrat F; Marteau P;
    Gut; 2011 Feb; 60(2):198-203. PubMed ID: 21115547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy outcome following in utero exposure to azathioprine: A French comparative observational study.
    Alami Z; Agier MS; Ahid S; Vial T; Dautriche A; Lagarce L; Toutain A; Cherrah Y; Jonville-Bera AP
    Therapie; 2018; 73(3):199-207. PubMed ID: 29100610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Follow-up of 'medications and pregnancy' at the Midi-Pyrenees Pharmacovigilance Center'].
    Lemoine T; Lacroix I; Lapeyre-Mestre M; Montastruc JL; Damase-Michel C
    Therapie; 2001; 56(3):287-93. PubMed ID: 11475810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous Anti-TNFα Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION).
    Luu M; Benzenine E; Doret M; Michiels C; Barkun A; Degand T; Quantin C; Bardou M
    Am J Gastroenterol; 2018 Nov; 113(11):1669-1677. PubMed ID: 29961771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England.
    Wilton LV; Pearce GL; Martin RM; Mackay FJ; Mann RD
    Br J Obstet Gynaecol; 1998 Aug; 105(8):882-9. PubMed ID: 9746382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of existing electronic health care databases to evaluate medication safety in pregnancy: Triptan exposure in pregnancy as a case study.
    Yusuf A; Chia V; Xue F; Mikol DD; Bollinger L; Cangialose C
    Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1309-1315. PubMed ID: 30240072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers.
    Viktil KK; Engeland A; Furu K
    Scand J Rheumatol; 2012 May; 41(3):196-201. PubMed ID: 22401133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.